Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Accumulated Depreciation (2024 - 2025)

Historic Accumulated Depreciation for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $3.9 million.

  • Kura Oncology's Accumulated Depreciation rose 2599.35% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 2599.35%. This contributed to the annual value of $3.3 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Kura Oncology reported Accumulated Depreciation of $3.9 million as of Q3 2025, which was up 2599.35% from $3.7 million recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's Accumulated Depreciation peaked at $3.9 million during Q3 2025, and registered a low of $2.7 million during Q1 2024.